The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space

Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of the type V receptor tyrosine kinases VEGFR-1, -2 and -3. In addition, VEGFs interact with co-receptors such as neuropilins, integrins, semaphorins or heparansulfate glycosaminoglycans. Li...

Full description

Bibliographic Details
Main Authors: P Berger, K Ballmer-Hofer
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2011-12-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/1395
_version_ 1811194090915627008
author P Berger
K Ballmer-Hofer
author_facet P Berger
K Ballmer-Hofer
author_sort P Berger
collection DOAJ
description Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of the type V receptor tyrosine kinases VEGFR-1, -2 and -3. In addition, VEGFs interact with co-receptors such as neuropilins, integrins, semaphorins or heparansulfate glycosaminoglycans. Ligand binding dimerises the receptors and activates their intracellular tyrosine kinase domains, resulting in phosphorylation of tyrosine residues acting as docking sites for intracellular signalling molecules. Ligand-induced receptor is internalised and then transported through early, late, and recycling endosomes, and finally degraded by proteasomal or lysosomal pathways. Biological output by VEGF is mediated through distinct receptor/co-receptor complexes and generates signals in all cellular compartments triggering cellular responses such as cell migration, cell proliferation, vessel formation and maturation, as well as changes in vessel fenestration, constriction and permeability. Here we review recent experiments showing how VEGFR-2 is transported through intracellular vesicular compartments specified by Rab family GTPases, and discuss how different VEGF-A isoforms specify intracellular receptor trafficking. We also discuss how the biological consequences of aberrant receptor trafficking bear on the development of vascular disease.
first_indexed 2024-04-12T00:20:20Z
format Article
id doaj.art-92242ae9cf124ba28b20ca2a861e99b9
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-12T00:20:20Z
publishDate 2011-12-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-92242ae9cf124ba28b20ca2a861e99b92022-12-22T03:55:44ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972011-12-01141495010.4414/smw.2011.13318The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic spaceP BergerK Ballmer-Hofer Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of the type V receptor tyrosine kinases VEGFR-1, -2 and -3. In addition, VEGFs interact with co-receptors such as neuropilins, integrins, semaphorins or heparansulfate glycosaminoglycans. Ligand binding dimerises the receptors and activates their intracellular tyrosine kinase domains, resulting in phosphorylation of tyrosine residues acting as docking sites for intracellular signalling molecules. Ligand-induced receptor is internalised and then transported through early, late, and recycling endosomes, and finally degraded by proteasomal or lysosomal pathways. Biological output by VEGF is mediated through distinct receptor/co-receptor complexes and generates signals in all cellular compartments triggering cellular responses such as cell migration, cell proliferation, vessel formation and maturation, as well as changes in vessel fenestration, constriction and permeability. Here we review recent experiments showing how VEGFR-2 is transported through intracellular vesicular compartments specified by Rab family GTPases, and discuss how different VEGF-A isoforms specify intracellular receptor trafficking. We also discuss how the biological consequences of aberrant receptor trafficking bear on the development of vascular disease. https://www.smw.ch/index.php/smw/article/view/1395CancerendocytosisNeuropilinSignalingTraffickingVEGF
spellingShingle P Berger
K Ballmer-Hofer
The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
Swiss Medical Weekly
Cancer
endocytosis
Neuropilin
Signaling
Trafficking
VEGF
title The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
title_full The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
title_fullStr The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
title_full_unstemmed The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
title_short The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space
title_sort reception and the party after how vascular endothelial growth factor receptor 2 explores cytoplasmic space
topic Cancer
endocytosis
Neuropilin
Signaling
Trafficking
VEGF
url https://www.smw.ch/index.php/smw/article/view/1395
work_keys_str_mv AT pberger thereceptionandthepartyafterhowvascularendothelialgrowthfactorreceptor2explorescytoplasmicspace
AT kballmerhofer thereceptionandthepartyafterhowvascularendothelialgrowthfactorreceptor2explorescytoplasmicspace
AT pberger receptionandthepartyafterhowvascularendothelialgrowthfactorreceptor2explorescytoplasmicspace
AT kballmerhofer receptionandthepartyafterhowvascularendothelialgrowthfactorreceptor2explorescytoplasmicspace